Development of mullerian inhibiting substance as an anti-cancer drug.
Cate
R L
RL
Ninfa
E G
EG
Pratt
D J
DJ
MacLaughlin
D T
DT
Donahoe
P K
PK
D000818:Animals; D054304:Anti-Mullerian Hormone; D000970:Antineoplastic Agents; D002417:Cattle; D002460:Cell Line; D003001:Cloning, Molecular; D005796:Genes; D006023:Glycoproteins; D006131:Growth Inhibitors; D006801:Humans; D008297:Male; D009095:Mullerian Ducts; D014176:Protein Biosynthesis; D011994:Recombinant Proteins / Q000627:therapeutic use*; D013735:Testicular Hormones / Q000235:genetics / Q000627:therapeutic use*; D014158:Transcription, Genetic
D000970:Antineoplastic Agents; D006023:Glycoproteins; D006131:Growth Inhibitors; D011994:Recombinant Proteins; D013735:Testicular Hormones; D054304:Anti-Mullerian Hormone